Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. - Wikidata - wikimedia - TriplyDB

Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.

Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.

http://www.wikidata.org/entity/Q34530870

about

The Role of PPARs in Cancer Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands Colorectal cancer models for novel drug discovery Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer Chemotherapy and chemoprevention by thiazolidinediones Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Insulin signaling regulates a functional interaction between adenomatous polyposis coli and cytoplasmic dynein.Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro.The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells.PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study.Gastrointestinal Cytoprotection by PPARγ Ligands.Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.Autonomous inhibition of apoptosis correlates with responsiveness of colon carcinoma cell lines to ciglitazone.The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents.Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study.Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.Peroxisome proliferator-activated receptors and progression of colorectal cancer.Macrophages, PPARs, and Cancer.To Live or to Die: Prosurvival Activity of PPARgamma in Cancers.Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways Clinical Use of PPARgamma Ligands in Cancer.PPARs Mediate Lipid Signaling in Inflammation and Cancer.Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus.

P2860

Q21342955-280B971A-7D10-4D75-8B92-21EFB33594C5 Q24804408-437E6F7D-4460-49D5-B38A-B41743DA5FBB Q24810709-6F974CEA-9294-422C-A976-2C32A889BE38 Q26795724-37E5F119-32EA-4741-979A-4751DC5876F4 Q26829126-496C9331-7DBC-4D4A-9FC0-996041D2385D Q27011352-00735615-5264-4CD5-A270-9A71E570C483 Q27687166-1AFED54C-9064-4A0C-8001-CA500EBA685F Q28910200-96B60DFB-9015-4BD1-ACD1-8A0F37C0C7BF Q33744855-65F0BCAD-6A8B-468E-9736-D151B3D443ED Q33817896-32BE54B5-08AD-45CC-9D68-190D63CAD194 Q33830757-02B8E286-D5F0-43B0-BF38-180F7686CAB0 Q33991703-1A7C2E22-0036-47E0-BDD6-2D0E30A0A4B2 Q34089258-AF5008EB-DF1E-4438-98AB-2DD97A8AA1AF Q34159427-82490163-8719-4CAE-B847-AD9266FE936C Q34380511-72C3BE7B-1034-4239-9243-8C814F71730A Q34524549-FDB6735A-9F4D-4FE9-88DA-1E86D008415D Q34635002-A4503ECE-4BC3-45BA-B290-8D7E1A79EEF3 Q34680692-A5B06E4E-BE51-4E2A-BAB4-181F1FF04441 Q34772160-57158FF8-6746-4834-97BE-479FE35E0B71 Q34804346-8737A8EA-596B-4332-BC0C-1DF06D693821 Q35083721-C68245DC-BD6D-4E88-8874-F810440EFF71 Q35417323-FE6858A7-13F5-44E4-99B7-8271FC0B4A2F Q35458969-7B64B97E-62C8-45DC-8990-6B62FE8D6AC9 Q35759627-9554E0CA-C42C-406D-B880-183FA56702B0 Q36041152-E01B1DC4-1DBB-4EAD-981A-A3F38CAAF129 Q36059703-9D9A8DD3-0687-45DF-A7A8-D1B552D6B1F9 Q36238466-A5BE2499-D978-48EB-A1D6-6FA1279E7DD3 Q36352434-5A86C039-BD33-49DB-A8DE-69FD79C4C3D1 Q36385805-7E4AB8E6-5445-46AF-A113-EBCA6265AD67 Q36499766-C89E8117-EC80-42E4-8E2C-5B8A7F3D21D1 Q36560240-8A8B2AD4-71BB-4C28-980F-29F61A769391 Q36580628-00C618D1-E973-4560-B210-1FF8C1619F02 Q36710291-DE5ECC54-EB82-46B3-93AF-FCAE0EC79E81 Q36743885-A08E6D4B-78F9-4A61-A1A0-93E057CF2D05 Q36867693-19409EA7-7B5C-4AAC-A5A6-5F959E4CA87E Q36971168-E82BBCAB-60EB-416D-8B1B-A96B0CFBEC55 Q37001526-9BB1E7C6-3F4D-46CA-B925-8A8CA1D18326 Q37021288-1B30E9BC-B0BF-4496-B47B-CB9E5E0C03CC Q37021709-B1ACBAB5-3714-4B77-AD2A-97B8D3EC8BEA Q37066317-32ADD6CB-C122-4221-ADC3-92F3EB811CE7

P2860

Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.

http://www.wikidata.org/entity/Q34530870

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@ast

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@en

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@nl

type

label

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@ast

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@en

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@nl

prefLabel

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@ast

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@en

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@nl

P1433

Q34530870-A553A9C2-FEDE-47F9-A359-CD96A89930F0

P1476

Q34530870-9C13FB5F-EFA4-4171-8865-9BF10418156D

P2093

Q34530870-01E8C28B-B741-4A78-9FB3-00D0C967FC9F

Q34530870-02BAF899-EC03-4FFC-977C-9CB97A0BADD1

Q34530870-22E40354-E8DA-4117-9711-5A0D69D80D45

Q34530870-2553441F-4048-4FF5-BB13-465D84DE2CA6

Q34530870-4DD29370-1FCF-4C88-BAC3-6FE4B4D603F3

Q34530870-98A63737-1804-4130-BCDB-BEA820BE3506

Q34530870-A52FB1A6-FC5C-421E-89C3-B6FB6C1212A0

Q34530870-A65EF12F-5445-4966-9936-993F1CC1503E

Q34530870-D86866BC-8656-4B96-BAAB-D6D088467BA0

Q34530870-F7A6C68C-518C-4F98-82E1-C7B7BECFC8E7

P304

Q34530870-704CFA02-B3E3-4124-A8FD-6D59D66ECE77

P31

Q34530870-6F60E09F-1678-4039-8B2F-F07818EB26DD

P356

Q34530870-9DE1FA14-491D-49D6-968C-A934872D5286

P407

Q34530870-B51B3042-C193-43DB-B086-D8910EBFE442

P433

Q34530870-2A99A3FB-0C78-4284-B492-D06407FE7611

P478

Q34530870-9351D286-8BD6-4E11-BACE-E05547FE2337

P577

Q34530870-B203B1D8-9890-43C3-8427-0E95A911D4F6

P5875

Q34530870-DF7B4A25-3E6E-44AB-BAB9-91DC8A8354A8

P698

Q34530870-BC731D44-15C5-4BD4-8CD7-C0E5B6A89A95

P356

GAST.2003.50067

P1433

Gastroenterology

P1476

Peroxisome proliferator-activa ...... duced by azoxymethane in mice.

@en

P2093

Atsushi Nakajima

http://www.w3.org/2001/XMLSchema#string

Emi Osawa

http://www.w3.org/2001/XMLSchema#string

Hisahiko Sekihara

http://www.w3.org/2001/XMLSchema#string

Hitoshi Nakagama

http://www.w3.org/2001/XMLSchema#string

Koichiro Wada

http://www.w3.org/2001/XMLSchema#string

Masako Ochiai

http://www.w3.org/2001/XMLSchema#string

Nobutaka Fujisawa

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Matsuhashi

http://www.w3.org/2001/XMLSchema#string

Satoko Ishimine

http://www.w3.org/2001/XMLSchema#string

Takashi Kadowaki

http://www.w3.org/2001/XMLSchema#string

P304

361-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/GAST.2003.50067

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10926633

http://www.w3.org/2001/XMLSchema#string

P698

12557142

http://www.w3.org/2001/XMLSchema#string